Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
One of the biggest imaging OEMs is offering healthcare providers using its radiography systems a third party’s AI toolset for detecting lung abnormalities.
Harvard researchers have demonstrated a way to cut through tangles of irrelevant information in electronic health records (EHRs) while applying machine learning to spot patterns indicative of specific disease markers.
For AI to make a truly damaging dent in COVID-19’s armor, developers need to better connect big-data analytics with regularly refreshed input from frontline healthcare workers.
In a pilot study of 16 patients, the system’s recommendations were deemed safe by expert endocrinologists at a clip of more than 99% over the course of four weeks.
Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.